Form 4 for VCYT VERACYTE, INC.
Accepted 2026-06-04 21:38:26 ET · period of report 2026-06-02 · accession 0001539796-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-04 21:38 | 2026-06-02 | VCYT | Stapley Marc | CEO, Dir | F - Tax | $47.80 | -9,012 | 440.5K | -2% | -$430.8K |
| DT | 2026-06-04 21:38 | 2026-06-04 | VCYT | Stapley Marc | CEO, Dir | M - OptEx | $36.60 | +138.1K | 578.5K | +31% | +$5.05M |
| DT | 2026-06-04 21:38 | 2026-06-04 | VCYT | Stapley Marc | CEO, Dir | S - Sale+OE | $50.12 | -138.1K | 440.5K | -24% | -$6.92M |
| DT | 2026-06-04 21:38 | 2026-06-04 | VCYT | Stapley Marc | CEO, Dir | M - OptEx | $0.00 | -138.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-02 | F | D | 9,012 | $47.80 | 440,494 | D | — | — | (F1) Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale. (F2) Due to an administrative error, shares of common stock acquired by the Reporting Person under the Veracyte, Inc. Employee Stock Purchase Plan on July 31, 2025 were incorrectly reported as 529 shares of common stock instead of 382 shares of common stock in a Form 4 filed on September 4, 2025, and these shares were overreported in subsequent Forms 4 filed by the Reporting Person. This column reflects the corrected balance. |
| 2 | Common | Common Stock | 2026-06-04 | M | A | 138,051 | $36.60 | 578,545 | D | — | — | (F3) The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. |
| 3 | Common | Common Stock | 2026-06-04 | S | D | 138,051 | $50.12 | 440,494 | D | — | — | (F3) The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. (F4) Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
| 4 | Derivative | Stock Option (right to buy) | 2026-06-04 | M | D | 138,051 | $0.00 | 0 | D | $36.60 · — to 2031-06-01 | 138,051 Common Stock | (F3) The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. (F5) The option is fully vested. |